Oaktree Acquisition Corp. III Life Sciences (OACCU) Stock Price, News & Analysis

Company Overview

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU) is a special purpose acquisition company formed to pursue business combinations with firms operating in the life sciences sector. Incorporated in the Marshall Islands, the company seeks targets in biopharmaceuticals, medical devices, diagnostics and related healthcare fields. Its mission is to merge with or acquire a company that can benefit from Oaktree Capital Management’s deep industry expertise and capital resources.

The SPAC completed its initial public offering in 2021, raising capital through the issuance of units, each consisting of one share of common stock and a fraction of a redeemable warrant. Proceeds from the offering are held in a trust account and will be used to fund a merger or acquisition of one or more qualifying life sciences businesses. The investment focus is principally on companies based in North America and Europe that are developing innovative therapies and technologies addressing significant unmet medical needs.

Sponsored by Oaktree Capital Management, a leading global alternative investment firm, Oaktree Acquisition Corp. III Life Sciences benefits from a management team experienced in private equity, credit and public market transactions. While the SPAC’s board and officers are appointed by its sponsor, the governance structure is designed to ensure rigorous due diligence and oversight throughout the business combination process. Upon closing a transaction, the company will transition into an operating entity dedicated to advancing scientific innovation and delivering value to its shareholders.

Key Stats

• Today's Range: $10.46 to $10.75
• 50-Day Range: $10.48 to $11.06
• 52-Week Range: $9.99 to $11.06
• Volume: 4,135 shs
• Average Volume: 5,099 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OACCU Stock Analysis - Frequently Asked Questions

How have OACCU shares performed this year?

Oaktree Acquisition Corp. III Life Sciences' stock was trading at $10.13 at the beginning of 2025. Since then, OACCU shares have increased by 4.3% and is now trading at $10.57.

When did Oaktree Acquisition Corp. III Life Sciences IPO?

Oaktree Acquisition Corp. III Life Sciences (OACCU) raised $175 million in an initial public offering (IPO) on Thursday, October 24th 2024. The company issued 17,500,000 shares at a price of $10.00 per share. Jefferies, Citigroup and UBS Investment Bank acted as the underwriters for the IPO.

How do I buy shares of Oaktree Acquisition Corp. III Life Sciences?

Shares of OACCU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Investment Offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:OACCU
• CIK: 2029769
• Web: N/A
• Phone: (213) 830-6300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A